Traditional Chinese Medicine Industry welcomes Policy "dividend"

In the first half of this year, a number of favorable policies on medicine have been introduced one after another, in addition to the Central Health Service Development Plan of traditional Chinese Medicine (2015-2020) and the Protection and Development Plan of Chinese Medicinal Materials (2015-2020) (hereinafter referred to as the "Plan"). The local government has also followed suit. Yunnan has introduced a new government to promote the development of traditional Chinese medicine and ethnic medicine industry, and Guizhou Province has also issued relevant policies to increase support for the development of Miao medicine. Among them, the notice of "Plan for the Protection and Development of Chinese Medicinal Materials" was jointly issued by more than a dozen departments, including the General Office of the State Council, and is the first national special plan for the protection and development of traditional Chinese medicinal materials in China.

This is China's first national special plan for the protection and development of traditional Chinese medicine, which is planned to 2020 in many fields such as technology, circulation and financial support. and clearly put forward the key construction of 100 kinds of endangered and scarce traditional Chinese medicine planting and breeding base, including Cordyceps sinensis. This is undoubtedly a great benefit for those enterprises that develop and utilize the deep processing of Cordyceps sinensis.

Traditional Chinese medicine is the material basis for the inheritance and development of traditional Chinese medicine, and it is also a strategic resource related to the national economy and people's livelihood. The protection and development of traditional Chinese medicine is of great significance for deepening the reform of the medical and health system, improving people's health, developing strategic emerging industries, increasing farmers' income and promoting the construction of ecological civilization.

However, the protection and development of traditional Chinese medicine in China are facing severe challenges. On the one hand, due to the reduction of land resources and the deterioration of the ecological environment, some wild traditional Chinese medicine resources have been lost and exhausted, and the problem of shortage of traditional Chinese medicine supply has become increasingly prominent. On the other hand, the production of traditional Chinese medicine is relatively backward, and the abuse of chemical fertilizers, pesticides and growth regulators is more common, which leads to the decline of the quality of traditional Chinese medicine, affects the quality and clinical efficacy of traditional Chinese medicine, and damages the reputation of traditional Chinese medicine. In addition, the production, operation and management of traditional Chinese medicine is relatively extensive, the exchange of supply and demand information is not smooth, and the price fluctuation is too large, which also hinders the healthy development of the traditional Chinese medicine industry.

The "Plan" emphasizes that special breeding bases should be built for endangered and scarce traditional Chinese medicine. We will focus on building wild tending bases for 100 species of musk, Chenxiang, Cordyceps sinensis, Dendrobium and other endangered and scarce Chinese medicinal materials. At the same time, we should also focus on developing important technologies such as mechanized production and modern processing to improve the modern production level of traditional Chinese medicine.

The policy dividend brings new opportunities for the development of the traditional Chinese medicine industry, especially the endangered and scarce Chinese herbal medicines. In the subdivision of these endangered and scarce traditional Chinese medicine, Cordyceps sinensis can only grow on its own in the plateau where the temperature, humidity and bacteria are suitable, so it becomes more precious, and its annual quantity is also a relatively stable value. In addition, the deep processing of Cordyceps sinensis has become the development trend of the industry, and its deep processing has two directions: one is to use it as a single raw material for deep processing, such as polar grass buccal tablets in spring in Qinghai; the other is to carry out deep processing of Cordyceps sinensis with other medicinal materials, including compound Biejia Ruangan tablets from Inner Mongolia Forui Medical Technology Co., Ltd., Shenlingcao oral liquid from Jiang traditional Chinese Medicine Co., Ltd.

The industry predicts that the future Cordyceps sinensis industry will usher in a good opportunity for market blowout, especially the promotion of deep processing of Cordyceps sinensis is the main driving force for the future growth of the industry. Some analysts in the traditional Chinese medicine industry predict that by 2018, the market sales of Cordyceps sinensis products will exceed 65 billion yuan, with an average annual growth rate of more than 10%. With the continuous increase in the proportion of the deep processing industry, the scale of the deep processing industry will grow by about 20% in the next 5-10 years.

Not only that, in the context of favorable policies and blue market, the leading enterprises of deep processing will be the first to benefit. At present, Qinghai Spring, as the only leading enterprise in the field of deep processing of raw materials of Cordyceps sinensis, its representative product "polar grass 5X Cordyceps sinensis" pure powder series has become the darling of the market. In the field of deep processing of Cordyceps sinensis, spring in Qinghai has been outstanding.

While speeding up their own development, excellent leading enterprises will also enhance the reform and upgrading of the whole Cordyceps sinensis industry and promote the healthy and stable development of the whole industry. In this process, the relevant government management agencies continue to adjust the corresponding administrative management system because of the development of leading enterprises, which not only standardize the behavior of industries and enterprises, but also protect the development of related industries and enterprises. it will play a beneficial role in promoting the development of Cordyceps sinensis industry and even the whole traditional health industry.